Literature DB >> 9378151

Expression of basic fibroblast growth factor and its mRNA in advanced ovarian cancers.

J Fujimoto1, S Ichigo, M Hori, R Hirose, H Sakaguchi, T Tamaya.   

Abstract

To investigate whether growth, invasion and metastasis of ovarian cancer cells is associated with neovascularization, the expression of basic fibroblast growth factor (FGF) and its mRNA in ovarian cancers and normal ovaries as controls were determined by ELISA and reverse transcription-polymerase chain reaction-Southern blot, respectively. The relationships between the expression and the histological grading, clinical backgrounds or clinical staging in ovarian cancers were analyzed. The levels of basic FGF and its mRNA were significantly higher in advanced primary ovarian cancers, regardless of histological types and some clinical backgrounds. Therefore, this status might contribute to the acceleration of growth, invasion, and metastasis with neovascularization in advanced ovarian cancers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378151

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

Review 1.  Investigational agents in development for the treatment of ovarian cancer.

Authors:  Shannon N Westin; Thomas J Herzog; Robert L Coleman
Journal:  Invest New Drugs       Date:  2012-06-04       Impact factor: 3.850

2.  A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells.

Authors:  H Naora; Y Q Yang; F J Montz; J D Seidman; R J Kurman; R B Roden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.

Authors:  Samar Masoumi-Moghaddam; Afshin Amini; Ai-Qun Wei; Gregory Robertson; David L Morris
Journal:  Oncotarget       Date:  2015-09-29

4.  Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer.

Authors:  G Smith; M T H Ng; L Shepherd; C S Herrington; C Gourley; M J Ferguson; C R Wolf
Journal:  Br J Cancer       Date:  2012-09-18       Impact factor: 7.640

5.  Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells.

Authors:  Man-Tat Lau; Wai-Kin So; Peter C K Leung
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

6.  Expression of IP-10 related to angiogenesis in uterine cervical cancers.

Authors:  E Sato; J Fujimoto; H Toyoki; H Sakaguchi; S M Alam; I Jahan; T Tamaya
Journal:  Br J Cancer       Date:  2007-05-15       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.